| # |
PMID |
Sentence |
| 1 |
10903795
|
Somatostatin down-modulates a number of immune functions, among others lymphocyte proliferation, immunoglobulin production and the release of proinflammatory cytokines such as IFN-g.
|
| 2 |
10903795
|
In many of these models somatostatin appears to antagonise the effects of another neuropeptide, substance P.
|
| 3 |
10903795
|
A somatostatin-substance P immunoregulatory circuit has been proposed to operate within murine Schistosoma mansoni-induced granulomas.
|
| 4 |
10903795
|
In this review we extend the model of the somatostatin-substance P immunoregulatory circuit to include data derived from other biological systems, and those relying on human clinical situations.
|
| 5 |
10903795
|
Somatostatin down-modulates a number of immune functions, among others lymphocyte proliferation, immunoglobulin production and the release of proinflammatory cytokines such as IFN-g.
|
| 6 |
10903795
|
In many of these models somatostatin appears to antagonise the effects of another neuropeptide, substance P.
|
| 7 |
10903795
|
A somatostatin-substance P immunoregulatory circuit has been proposed to operate within murine Schistosoma mansoni-induced granulomas.
|
| 8 |
10903795
|
In this review we extend the model of the somatostatin-substance P immunoregulatory circuit to include data derived from other biological systems, and those relying on human clinical situations.
|
| 9 |
10903795
|
Somatostatin down-modulates a number of immune functions, among others lymphocyte proliferation, immunoglobulin production and the release of proinflammatory cytokines such as IFN-g.
|
| 10 |
10903795
|
In many of these models somatostatin appears to antagonise the effects of another neuropeptide, substance P.
|
| 11 |
10903795
|
A somatostatin-substance P immunoregulatory circuit has been proposed to operate within murine Schistosoma mansoni-induced granulomas.
|
| 12 |
10903795
|
In this review we extend the model of the somatostatin-substance P immunoregulatory circuit to include data derived from other biological systems, and those relying on human clinical situations.
|